» Articles » PMID: 35515804

Cerium Oxide Nanoparticles: Properties, Biosynthesis and Biomedical Application

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 6
PMID 35515804
Authors
Affiliations
Soon will be listed here.
Abstract

Nanotechnology is the branch of science which deals with particles ranging between 1-100 nm. These particles are called nanoparticles, and they exhibit unique electronic, optical, magnetic, and mechanical properties, which make them different from the bulk material. These properties of nanomaterials help them to find a variety of applications in the biomedical, agricultural, and environmental domains. Cerium oxide nanoparticles have gained a lot of attention as a potential future candidate for ending various kinds of problems by exhibiting redox activity, free radical scavenging property, biofilm inhibition, Synthesis of these nanoparticles can be performed very easily by utilizing chemical or biological methods. But in this review, the focus is laid on the biosynthesis of these nanoparticles; as the biosynthesis method makes the cerium oxide nanoparticle less toxic and compatible with the living tissues, which helps them to find their path as an anticancer, anti-inflammatory and antibacterial agents. The pre-existing reviews have only focused on details relating to properties/applications/synthesis; whereas this review draws attention towards all the aspects in single review covering all the details in depth such as biosynthesis methods and its effect on the living tissues, along with properties, biomedical applications (diagnostic and therapeutic) and future outlook of the cerium oxide nanoparticle.

Citing Articles

Hollow cerium nanoparticles synthesized by one-step method for multienzyme activity to reduce colitis in mice.

Mi L, Zhang K, Ma J, Yao J, Tong Y, Bao Z World J Gastroenterol. 2025; 31(5):98732.

PMID: 39926211 PMC: 11718602. DOI: 10.3748/wjg.v31.i5.98732.


Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes.

Yadav V, Gupta R, Assiri A, Uddin J, Ishaqui A, Kumar P J Funct Biomater. 2025; 16(1).

PMID: 39852564 PMC: 11766075. DOI: 10.3390/jfb16010008.


Antibacterial activity of copper-decorated CeO nanoparticles and preparation of antifouling polyethersulfone surface.

Sener L, Ozdemir S, Yalcin M, Gulcan M, Dizge N Heliyon. 2024; 10(23):e40818.

PMID: 39717578 PMC: 11665354. DOI: 10.1016/j.heliyon.2024.e40818.


Study of Mesostructured CeO Synthesis via Nanocasting Using SBA-15 as a Template: Influence of the Cerium Precursor.

Moreno de la Calle A, Vizcaino A, Carrero A, Calles J, Megia P Int J Mol Sci. 2024; 25(23).

PMID: 39684726 PMC: 11641326. DOI: 10.3390/ijms252313016.


Biodetection Strategies for Selective Identification of Candidiasis.

Verma R, Gaba S, Chauhan N, Chandra R, Jain U Indian J Microbiol. 2024; 64(4):1461-1476.

PMID: 39678986 PMC: 11645395. DOI: 10.1007/s12088-024-01288-5.


References
1.
Pourkhalili N, Hosseini A, Nili-Ahmadabadi A, Rahimifard M, Navaei-Nigjeh M, Hassani S . Improvement of isolated rat pancreatic islets function by combination of cerium oxide nanoparticles/sodium selenite through reduction of oxidative stress. Toxicol Mech Methods. 2012; 22(6):476-82. DOI: 10.3109/15376516.2012.673093. View

2.
Rzigalinski B, Meehan K, Davis R, Xu Y, Miles W, Cohen C . Radical nanomedicine. Nanomedicine (Lond). 2007; 1(4):399-412. DOI: 10.2217/17435889.1.4.399. View

3.
Waris G, Ahsan H . Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006; 5:14. PMC: 1479806. DOI: 10.1186/1477-3163-5-14. View

4.
Arumugam A, Karthikeyan C, Hameed A, Gopinath K, Gowri S, Karthika V . Synthesis of cerium oxide nanoparticles using Gloriosa superba L. leaf extract and their structural, optical and antibacterial properties. Mater Sci Eng C Mater Biol Appl. 2015; 49:408-415. DOI: 10.1016/j.msec.2015.01.042. View

5.
Husseini G, Pitt W . Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev. 2008; 60(10):1137-52. PMC: 2490710. DOI: 10.1016/j.addr.2008.03.008. View